Angiotech

    <p class=default>
      
        07:39 PM, November 11, 2006
      
    </p>

<p>

      
        Got a plug on cnbc Friday.  ? Steve Blackman recom it.
      
    </p>

<p>

      
        DES drug eluting stents have been in trouble ... ? higher death rate vs historic controls
      
    <br/>

      
        BUT being implanted in much sicker patients and in more arteries.
      
    <br/>

      
        Cypher stent from JNJ ... also in trouble.
      
    </p>

<p>

      
        Some notion that the 750M that Angiotech paid for the technology was too much
      
    <br/>

      
        See msgs from acricketeer  (prob. Howard Palefsky).
      
    </p>

<p>

      
        
      
    <br/>

      
        08:42 PM, May 08, 2006
      
    <br/>

      
        ANPI  teamed up with BSX to create Taxol (paclitaxel) stents. see tech review article.
      
    </p>

<p>

      
        
      
    </p>